Oracle
ORCL
Salesforce
CRM
Microsoft
MSFT
Cisco
CSCO
Broadcom
AVGO
US Stock MarketDetailed Quotes
NX Quanex Building Products
- 22.690
- -0.410-1.77%
Close Jan 8 16:00 ET
- 22.690
- 0.0000.00%
Post 17:36 ET
1.07BMarket Cap25.21P/E (TTM)
23.130High22.170Low329.18KVolume22.510Open23.100Pre Close7.49MTurnover0.78%Turnover Ratio25.21P/E (Static)47.26MShares38.97252wk High1.06P/B956.21MFloat Cap22.17052wk Low0.32Dividend TTM42.14MShs Float38.972Historical High1.41%Div YieldTTM4.16%Amplitude4.257Historical Low22.751Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Quanex Building Products Stock Forum
In reaction to earnings/guidance:
• $HashiCorp (HCP.US)$ +16.8%, $Lululemon Athletica (LULU.US)$ +9.7%, $PagerDuty (PD.US)$ +5%, $nCino (NCNO.US)$ +3.8% (also Bank Operating System selected by Rabobank Australia and New Zealand), $Broadcom (AVGO.US)$ +2.1%
Other news:
• $Ooma (OOMA.US)$ +3.5% (acquires Junction Networks also reports earnings)
• $Momentus (MNTS.US)$ +3.5% (files for $200 mln mixed securities shelf offering)
• $Humacyte (HUMA.US)$ +2.9% (fi...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet